These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17074480)

  • 1. Design of a selective chemical probe for class I PDZ domains.
    Fujii N; Shelat A; Hall RA; Guy RK
    Bioorg Med Chem Lett; 2007 Jan; 17(2):546-8. PubMed ID: 17074480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange.
    Weinman EJ; Wang Y; Wang F; Greer C; Steplock D; Shenolikar S
    Biochemistry; 2003 Nov; 42(43):12662-8. PubMed ID: 14580213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains.
    Mayasundari A; Ferreira AM; He L; Mahindroo N; Bashford D; Fujii N
    Bioorg Med Chem Lett; 2008 Feb; 18(3):942-5. PubMed ID: 18180157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity.
    van den Berk LC; Landi E; Walma T; Vuister GW; Dente L; Hendriks WJ
    Biochemistry; 2007 Nov; 46(47):13629-37. PubMed ID: 17979300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed evolution of PDZ variants to generate high-affinity detection reagents.
    Ferrer M; Maiolo J; Kratz P; Jackowski JL; Murphy DJ; Delagrave S; Inglese J
    Protein Eng Des Sel; 2005 Apr; 18(4):165-73. PubMed ID: 15820976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway.
    Zheng F; Jewell H; Fitzpatrick J; Zhang J; Mierke DF; Grigoryan G
    J Mol Biol; 2015 Jan; 427(2):491-510. PubMed ID: 25451599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating conformational entropy by increasing interdomain mobility in ligand binding regulation: a revisit to N-terminal tandem PDZ domains of PSD-95.
    Wang W; Weng J; Zhang X; Liu M; Zhang M
    J Am Chem Soc; 2009 Jan; 131(2):787-96. PubMed ID: 19072119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epithelial brush border Na+/H+ exchanger NHE3 associates with the actin cytoskeleton by binding to ezrin directly and via PDZ domain-containing Na+/H+ exchanger regulatory factor (NHERF) proteins.
    Cha B; Donowitz M
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):863-71. PubMed ID: 18430067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP.
    Kursula P; Kursula I; Massimi M; Song YH; Downer J; Stanley WA; Witke W; Wilmanns M
    J Mol Biol; 2008 Jan; 375(1):270-90. PubMed ID: 18001770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of long-range interactions in a PDZ domain by NMR, kinetics, and protein engineering.
    Gianni S; Walma T; Arcovito A; Calosci N; Bellelli A; Engström A; Travaglini-Allocatelli C; Brunori M; Jemth P; Vuister GW
    Structure; 2006 Dec; 14(12):1801-9. PubMed ID: 17161370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and screening of support-bound combinatorial peptide libraries with free C-termini: determination of the sequence specificity of PDZ domains.
    Joo SH; Pei D
    Biochemistry; 2008 Mar; 47(9):3061-72. PubMed ID: 18232644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sequential binding mechanism in a PDZ domain.
    Chi CN; Bach A; Engström A; Wang H; Strømgaard K; Gianni S; Jemth P
    Biochemistry; 2009 Aug; 48(30):7089-97. PubMed ID: 19496620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energetics of peptide recognition by the second PDZ domain of human protein tyrosine phosphatase 1E.
    Milev S; Bjelić S; Georgiev O; Jelesarov I
    Biochemistry; 2007 Jan; 46(4):1064-78. PubMed ID: 17240990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDZ domains: folding and binding.
    Jemth P; Gianni S
    Biochemistry; 2007 Jul; 46(30):8701-8. PubMed ID: 17620015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-limited unbinding of small peptides from PDZ domains.
    Cecconi F; De Los Rios P; Piazza F
    J Phys Chem B; 2007 Sep; 111(37):11057-63. PubMed ID: 17725342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general solid phase method for the preparation of diverse azapeptide probes directed against cysteine proteases.
    Kato D; Verhelst SH; Sexton KB; Bogyo M
    Org Lett; 2005 Dec; 7(25):5649-52. PubMed ID: 16321013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the NHERF family of PDZ scaffolding proteins in the regulation of salt and water transport.
    Seidler U; Singh AK; Cinar A; Chen M; Hillesheim J; Hogema B; Riederer B
    Ann N Y Acad Sci; 2009 May; 1165():249-60. PubMed ID: 19538313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDZ-domain-directed basolateral targeting of the peripheral membrane protein FRMPD2 in epithelial cells.
    Stenzel N; Fetzer CP; Heumann R; Erdmann KS
    J Cell Sci; 2009 Sep; 122(Pt 18):3374-84. PubMed ID: 19706687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degenerate specificity of PDZ domains from RhoA-specific nucleotide exchange factors PDZRhoGEF and LARG.
    Smietana K; Kasztura M; Paduch M; Derewenda U; Derewenda ZS; Otlewski J
    Acta Biochim Pol; 2008; 55(2):269-80. PubMed ID: 18542831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.
    Fujii N; Haresco JJ; Novak KA; Gage RM; Pedemonte N; Stokoe D; Kuntz ID; Guy RK
    Bioorg Med Chem Lett; 2007 Jan; 17(2):549-52. PubMed ID: 17055267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.